Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03058666 · ClinicalTrials.gov registry record · Phase 3
Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients
A Phase 3 study, sponsored by ONY.
- Completed
- Registry status
- Phase 3
- Development phase
- 477
- Enrollment target
NCT03058666: Completed Phase 3 study, sponsored by ONY.
NCT03058666 is a Phase 3 study that has completed, run by ONY. The registered enrollment target is 477 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03058666, a Phase 3 study, has completed, sponsored by ONY.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 477 participants
- Enrollment target
Study Summary
Study to test the hypothesis that aerosolized Infasurf can decrease the need for intubation and instillation of liquid surfactant to the airway.
Primary Outcome
Percent of at risk subjects receiving endotracheal intubation and instillation of surfactant within the first 72 hours.
Interventions
- DRUG Aerosolized Calfactant
- DEVICE Solarys
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2018-07-31 |
| Phase | Phase 3 |
What the finished NCT03058666 record still lists
NCT03058666 is an interventional study that assigns participants to a tested intervention. The registered 477 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (38% lower).
The record links to 0 conditions, and to 2 interventions - of which Aerosolized Calfactant is the first listed.
NCT03058666 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03058666 about?
NCT03058666 is a clinical study titled "Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients". Study to test the hypothesis that aerosolized Infasurf can decrease the need for intubation and instillation of liquid surfactant to the airway.
What is the current status of trial NCT03058666?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 477 participants. The study started on 2017-03-29. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT03058666?
The interventions under investigation include: Aerosolized Calfactant (DRUG), Solarys (DEVICE).
Who is sponsoring clinical trial NCT03058666?
This trial is sponsored by ONY, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03058666's enrollment target sits among peer trials
477 807th of 2000 higher than 1,193 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03911700 · 477 participants · NA
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
- NCT06997497 · 477 participants · Phase 3
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- NCT05446272 · 478 participants · NA
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
- NCT06172296 · 478 participants · Phase 3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI